FDA Updates Abiomed’s Heart Pump Labeling After Post-Approval Clinical Study
Executive Summary
The US Food and Drug Administration recently updated the labeling of Abiomed’s Impella RP System to reflect the latest results from a clinical study on the device. The FDA first approved the heart pump system in September 2017.